Prediction of One-Year Mortality Among 30-Day Survivors After Primary Percutaneous Coronary Interventions

• Published in: The American journal of cardiology 2006-03, Vol.97 (6), p.817-822
• Main Authors: Mehta, Rajendra H., O’Neill, William W., Harjai, Kishore J., Cox, David A., Brodie, Bruce R., Boura, Judy, Grines, Lorelei, Stone, Gregg W., Grines, Cindy L.
• Format: Article
• Language: English
• Subjects: Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal - therapeutic use; Biological and medical sciences; Cardiology; Cardiology. Vascular system; Coronary Angiography; Electrocardiography; Female; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments - therapeutic use; Logistic Models; Male; Medical prognosis; Medical sciences; Medical treatment; Middle Aged; Mortality; Myocardial Infarction - mortality; Myocardial Infarction - physiopathology; Myocardial Infarction - therapy; Platelet Aggregation Inhibitors - therapeutic use; Predictive Value of Tests; Randomized Controlled Trials as Topic; Risk factors; Stents; Survival Analysis; Survivor
• ISSN: 0002-9149; 1879-1913
• DOI: 10.1016/j.amjcard.2005.09.131

Little information exists on the features that influence risk factors for death at 1 year among 30-day survivors of ST-elevation myocardial infarction (STEMI) that is treated with primary percutaneous coronary intervention (PCI). Accordingly, we examined 3,280 patients with STEMI who were enrolled in Stent-PAMI and CADILLAC trials, were treated with primary PCI, and survived >30 days after STEMI. Death at 1 year occurred in 74 patients (2.3%) who survived >30 days after their index STEMI. Patients who died at 1 year were more likely to be older and women and have lower body weight and greater prevalence of previous stroke. Similarly, the sum of ST elevations, 3-vessel or left anterior coronary disease, and final Thrombolysis In Myocardial Infarction grade 70 years (odds ratio [OR] 3.3 95% confidence interval [CI] 1.9 to 5.7), weight